Skip to main content
editor.iijri@gmail.com
8007937666
e-ISSN: applied
The Intellecta International Journal of Research and Innovation

The Intellecta International Journal of Research and Innovation

LoginTrack Your Paper
Published

PRECLINICAL INVESTIGATION OF CURCUMIN IN RHEUMATOID ARTHRITIS: EVALUATION OF ITS ANTI-INFLAMMATORY EFFICACY IN IN VITRO AND ANIMAL MODELS

,

Published in Oct-Dec 2026 (Vol. 1, Issue 1, 2026)

PRECLINICAL INVESTIGATION OF CURCUMIN IN RHEUMATOID ARTHRITIS: EVALUATION OF ITS ANTI-INFLAMMATORY EFFICACY IN IN VITRO AND ANIMAL MODELS - Issue cover

Keywords

CurcuminRheumatoid ArthritisAnti-inflammatory ActivityAntioxidantAnimal ModelCytokinesPain ReliefJoint ProtectionPreclinical EvaluationNatural Therapy

Abstract

This study is an exploration of preclinical ef icacy and safety of Curcumin compared with conventional anti-inflammatory medication in the management of Rheumatoid Arthritis (RA) as a natural replacement. The models applied in Wistar rats were Collagen-Induced Arthritis (CIA) and Adjuvant-Induced Arthritis (AIA) after which the ef ects of Curcumin (200 mg/kg) were compared to Indomethacin (10 mg/kg). The measurement of parameters was done over 28 days: paw volume, arthritis score, body weight, and pain threshold with biochemical and histopathological parameters assessments. The ef ect of curcumin therapy on the treatment of arthritis showed a strong decrease in swelling, pain, inflammation of the joints, and the restoration of joint architecture and functions. Its anti-inflammatory and antioxidant ef ects were supported by serum cytokines (TNF- a, IL-1 b, IL-6) and markers of oxidative stress (MDA, GSH, and SOD). The histopathological analysis showed that the cartilage, as well as inflammatory infiltration, was preserved in the Curcumin-treated joints with minimal inflammatory infiltration. Notably, Curcumin did not exhibit any form of hepatic or gastrointestinal toxicity as opposed to the side ef ects of the normal NSAIDs. Altogether, Curcumin proved to be a powerful therapy with the ability to reduce RA symptoms, support functional performance, and increase the level of well-being. These findings aid the applicability of Curcumin as an adjunct/alternative and safe natural agent in the treatment of rheumatoid arthritis.

References

  1. [1]S. Malvankar, P. Jaiswal, P. P. Bhat, and S. Mehto, “Regulation of Cancer by Inflammasomes: From Inflammation to Tumorigenesis,” Frontiers in Immunology, vol. 16, p. 1611719, 2025.
  2. [2]M. Aleksandrowicz, M. Konop, M. Rybka, Ł. Mazurek, M. Stradczuk Mazurek, M. Kciuk, B. Bądzyńska, L. Dobrowolski, and M. Kuczeriszka, “Dysfunction of Microcirculation in Atherosclerosis: Implications of Nitric Oxide, Oxidative Stress, and Inflammation,” International Journal of Molecular Sciences, vol. 26, p. 6467, 2025.
  3. [3]E. Vataja, G. Ratti, A. Safa, M. Pagano, L. Ferrante, S. Meri, and K. Haapasalo, “Exploring the Intersection of Atherosclerosis and Alzheimer’s Disease: The Role of Inflammation and Complement Activation,” Inflammation Research, vol. 74, p. 102, 2025.
  4. [4]S. Sankar, B. Kalidass, J. Indrakumar, and G. K. Muthukaliannan, “NSAID Encapsulated Nanoparticles as a Targeted Therapeutic Platform for Modulating Chronic Inflammation and Inhibiting Cancer Progression: A Review,” Inflammopharmacology, vol. 33, pp. 2493–2522, 2025.
  5. [5]T. Satapathy, A. Minj, and M. Verma, “Impact of NSAIDs, Corticosteroids, DMARDs, Biologics and Their Comparisons with Natural Products in C Reactive Proteins (CRP) Linked Cardiovascular Disorders,” Inflammopharmacology, vol. 33, pp. 2537–2563, 2025.
  6. [6]S. Bindu, S. Mazumder, and U. Bandyopadhyay, “Non Steroidal Anti Inflammatory Drugs (NSAIDs) and Organ Damage: A Current Perspective,” Biochemical Pharmacology, vol. 180, p. 114147, 2020.
  7. [7]D. Huscher, K. Thiele, E. Gromnica Ihle, G. Hein, W. Demary, R. Dreher, A. Zink, and F. Buttgereit, “Dose Related Patterns of Glucocorticoid Induced Side Effects,” Annals of the Rheumatic Diseases, vol. 68, pp. 1119–1124, 2009.
  8. [8]K. Nakadate, N. Ito, K. Kawakami, and N. Yamazaki, “Anti Inflammatory Actions of Plant Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications,” International Journal of Molecular Sciences, vol. 26, p. 5206, 2025.
  9. [9]S. A. Shin, B. J. Joo, J. S. Lee, G. Ryu, M. Han, W. Y. Kim, H. H. Park, J. H. Lee, and C. S. Lee, “Phytochemicals as Anti Inflammatory Agents in Animal Models of Prevalent Inflammatory Diseases,” Molecules, vol. 25, p. 5932, 2020.
  10. [10]N. Yahfoufi, N. Alsadi, M. Jambi, and C. Matar, “The Immunomodulatory and Anti Inflammatory Role of Polyphenols,” Nutrients, vol. 10, p. 1618, 2018.
  11. [11]M. H. Shahrajabian and W. Sun, “The Golden Spice for Life: Turmeric with the Pharmacological Benefits of Curcuminoids Components, Including Curcumin, Bisdemethoxycurcumin, and Demethoxycurcumins,” Current Organic Synthesis, vol. 21, pp. 665–683, 2024.
  12. [12]H. Hatcher, R. Planalp, J. Cho, F. M. Torti, and S. V. Torti, “Curcumin: From Ancient Medicine to Current Clinical Trials,” Cellular and Molecular Life Sciences, vol. 65, pp. 1631–1652, 2008.
  13. [13]L. Slika and D. Patra, “Traditional Uses, Therapeutic Effects and Recent Advances of Curcumin: A Mini Review,” Mini Reviews in Medicinal Chemistry, vol. 20, pp. 1072–1082, 2020.
  14. [14]A. Marchiani, C. Rozzo, A. Fadda, G. Delogu, and P. Ruzza, “Curcumin and Curcumin Like Molecules: From Spice to Drugs,” Current Medicinal Chemistry, vol. 21, pp. 204–222, 2014.
  15. [15]Z. D. Koroljević, K. Jordan, J. Ivković, D. V. Bender, and P. Perić, “Curcuma as an Anti Inflammatory Component in Treating Osteoarthritis,” Rheumatology International, vol. 43, pp. 589–616, 2023.

Authors (2)

Vyas Yogesh Revashankar

Department Pharmaceutical Scie...

View all publications →

Gaurav Dubey

Department of Pharmacology, NI...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 2.0 MB
Format: PDF
ViewDownload

Article Information

Published in:

Oct-Dec 2026 (Vol. 1, Issue 1, 2026)

IIJRI110006

IIJRI-01-000010

62-73

2026-10-11

JATS XML

Article Impact

Views:38
Downloads:40

How to Cite

Yogesh Revashankar, V., & Dubey, G. (2026). PRECLINICAL INVESTIGATION OF CURCUMIN IN RHEUMATOID ARTHRITIS: EVALUATION OF ITS ANTI-INFLAMMATORY EFFICACY IN IN VITRO AND ANIMAL MODELS. The Intellecta International Journal of Research and Innovation, 1(1), 62-73. https://iijri.a1advancepublications.com/articles/IIJRI110006

Article Actions

Whatsapp